Factors Associated with the Development of CMV Viremia in High-Risk (D+/R-) Renal Transplant Patients on Valganciclovir Prophylaxis

被引：0
|
作者：
Limaye, A. [1 ]
Hauser, I. [2 ]
Loveless, M. [3 ]
Mu, Y. [3 ]
Blumberg, E. [4 ]
Jardine, A. [5 ]
Humar, A. [6 ]
机构：
[1] U Washington, Seattle, WA USA
[2] Goethe Univ Frankfurt, Frankfurt, Germany
[3] Genentech Inc, San Francisco, CA 94080 USA
[4] U Penn, Philadelphia, PA USA
[5] U Glasgow, Glasgow, Lanark, Scotland
[6] U Alberta, Edmonton, AB, Canada
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2012年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
144
引用
收藏
页码：69 / 69
页数：1
相关论文
共 50 条
  • [41] Prophylactic Therapy With Valgancyclovir in High-Risk (Cytomegalovirus D+/R-) Liver Transplant Recipients: A Single-Center Experience
    Montejo, M.
    Montejo, E.
    Gastaca, M.
    Valdivieso, A.
    Fernandez, J. R.
    Testillano, M.
    Gonzalez, J.
    Bustamante, J.
    Ruiz, P.
    Suarez, M. J.
    Ventoso, A.
    Rubio, M. C.
    de Urbina, J. Ortiz
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (06) : 2189 - 2191
  • [42] Extended Valganciclovir Prophylaxis in D+/R- Kidney Transplant Recipients is Associated With Long-Term Reduction in Cytomegalovirus Disease: Two-Year Results of the IMPACT Study
    Humar, Atul
    Limaye, Ajit P.
    Blumberg, Emily A.
    Hauser, Ingeborg A.
    Vincenti, Flavio
    Jardine, Alan G.
    Abramowicz, Daniel
    Ives, Jane A. L.
    Farhan, Mahdi
    Peeters, Patrick
    TRANSPLANTATION, 2010, 90 (12) : 1427 - 1431
  • [43] Breakthrough CMV Infection Rates Are Similar Using Low Dose vs. Standard Dose Valganciclovir in High Risk D+/R- Kidney or Kidney/Pancreas Transplantation
    Kaczmorski, S.
    Doares, W.
    Winfrey, S.
    Uloko, V.
    McArthur, M.
    Reeves-Daniel, A.
    Ghanta, M.
    Rogers, J.
    Farney, A.
    Stratta, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 470 - 470
  • [44] Burden of Primary CMV Infections Remains High Despite Six Months Valganciclovir Prophylaxis in High-Risk Kidney Transplant Recipients.
    Helantera, I.
    Ortiz, F.
    Loginov, R.
    Mannonen, L.
    Lempinen, M.
    Lautenschlager, I.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 533 - 533
  • [45] Impact of high-dose oral acyclovir prophylaxis on cytomegalovirus (CMV) disease in CMV high-risk renal transplant recipients
    Kletzmayr, J
    Kotzmann, H
    PopowKraupp, T
    Kovarik, J
    Klauser, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (02): : 325 - 330
  • [46] Effectiveness of Valganciclovir Cytomegalovirus Prophylaxis Protocol in High-Risk Liver Transplant Recipients
    Shivega, W. Gaya
    Samhan, Aya
    Bolognese, Alexandra
    Enestvedt, Kristian
    Maynard, Erin
    Orloff, Susan
    Scott, David
    Woodland, David
    Olyaei, Ali
    Connelly, Christopher
    AMERICAN JOURNAL OF TRANSPLANTATION, 2024, 24 (01) : S51 - S51
  • [47] Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxis
    Akalin, E
    Sehgal, V
    Ames, S
    Hossain, S
    Daly, L
    Barbara, M
    Bromberg, JS
    AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (06) : 731 - 735
  • [48] Resistance pattern of cytomegalovirus (CMV) after oral valganciclovir therapy in transplant recipients at high-risk for CMV infection
    Boutolleau, David
    Deback, Claire
    Bressollette-Bodin, Celine
    Varnous, Shaida
    Dhedin, Nathalie
    Barrou, Benoit
    Vernant, Jean-Paul
    Gandjbakhch, Iradj
    Imbert-Marcille, Berthe-Marie
    Agut, Henri
    ANTIVIRAL RESEARCH, 2009, 81 (02) : 174 - 179
  • [49] Incidence of Cytomegalovirus and Acute Rejection in D plus /R- Kidney Transplant Patients On Valganciclovir Prophylaxis After Medication Dose Adjustments
    D'Agostino, C.
    Delahunty, A.
    Henry, M.
    Theodoropoulos, N.
    Abdel-Rasoul, M.
    Winters, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 106 - 107
  • [50] Incidence and Characteristics of CMV Infection in High Risk (D plus R-) Kidney Transplant Recipients and the Utility of Monthly Surveillance After Routine Prophylaxis
    Bhattarai, M.
    Puttarajappa, C.
    Mour, G.
    Wu, C.
    Sood, P.
    Shah, N.
    Mehta, R.
    Tevar, A.
    Hariharan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
12345